WENDY L. YARNO - 02 Dec 2022 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role
Director
Signature
/s/ Leonard M. Greenstein
Issuer symbol
TARS
Transactions as of
02 Dec 2022
Net transactions value
$0
Form type
4
Filing time
06 Dec 2022, 16:59:07 UTC
Previous filing
06 Oct 2022
Next filing
20 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TARS Restricted Stock Units Award $0 +5,000 $0.000000 5,000 02 Dec 2022 Common Stock 5,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
F2 RSUs granted in connection with the Reporting Person's service as the Lead Independent Director. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.